FDA Approved: TAYTULLA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TAYTULLA, a combination oral contraceptive, submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• TAYTULLA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE)

Snippet

SUPPL AP for TAYTULLA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE)